
Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.

Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.

A look into the latest developments in biopharmaceutical manufacturing and facilities.

Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.

Taking a brief status check on the biologics supply chain and any impact on scale up operations.

How can sustainability and zero-carbon initiatives be achieved?

As oligo manufacturers scale up production from lab-scale to clinical and commercial scales, they may require volumes of hazardous materials that drive additional facility design considerations.